Biomerica Inc SEC filings BMRA

Biomerica Inc has 605 filings in SEC EDGAR's recent list, going back to Sep 28, 1995. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 15, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on May 31.

Form Description Filed Period
DEF 14A Proxy statement Oct 16, 2026 Oct 16, 2026
10-Q Quarterly report Oct 15, 2026 Aug 31, 2026
8-K Current report
Officer or director change
 Oct 15, 2026 Oct 9, 2026
EFFECT Filing Oct 7, 2026 —
EFFECT Filing Oct 7, 2026 —
10-K/A Amended annual report Sep 28, 2026 May 31, 2026
S-3 Shelf registration Sep 24, 2026 —
S-3 Shelf registration Sep 24, 2026 —
10-K Annual report Aug 31, 2026 May 31, 2026
8-K Current report
Material agreement, Unregistered share sale
 Aug 26, 2026 Aug 20, 2026
8-K Current report
Material agreement, New debt
 Jun 4, 2026 May 29, 2026
10-Q Quarterly report Apr 13, 2026 Feb 28, 2026
S-8 Employee stock plan registration Feb 27, 2026 —
10-Q Quarterly report Jan 14, 2026 Nov 30, 2025
8-K Current report
Shareholder vote results
 Dec 16, 2025 Dec 12, 2025
DEFA14A Additional proxy material Oct 23, 2025 —
DEF 14A Proxy statement Oct 20, 2025 Dec 12, 2025
10-Q Quarterly report Oct 14, 2025 Aug 31, 2025
PRE 14A Preliminary proxy statement Oct 9, 2025 Oct 9, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
 Oct 8, 2025 Oct 7, 2025
10-K/A Amended annual report Sep 26, 2025 May 31, 2025
10-K Annual report Aug 29, 2025 May 31, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
 Jun 6, 2025 Jun 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
 Apr 16, 2025 Apr 15, 2025
10-Q Quarterly report Apr 14, 2025 Feb 28, 2025
10-Q Quarterly report Jan 14, 2025 Nov 30, 2024
S-8 Employee stock plan registration Dec 20, 2024 —
8-K Current report
Shareholder vote results
 Dec 17, 2024 Dec 13, 2024
S-8 Employee stock plan registration Nov 25, 2024 —
8-K Current report
Listing notice
 Nov 6, 2024 Nov 6, 2024
10-Q Quarterly report Oct 15, 2024 Aug 31, 2024
DEF 14A Proxy statement Sep 30, 2024 Sep 30, 2024
PRE 14A Preliminary proxy statement Sep 20, 2024 Dec 13, 2024
10-K Annual report Aug 28, 2024 May 31, 2024
8-K Current report
Officer or director change
 Jun 28, 2024 Jun 26, 2024
424B5 Prospectus supplement May 10, 2024 —
8-K Current report
Material agreement, Listing notice
 May 10, 2024 May 7, 2024
10-Q Quarterly report Apr 12, 2024 Feb 29, 2024
10-Q Quarterly report Jan 16, 2024 Nov 30, 2023
8-K Current report
Shareholder vote results
 Dec 11, 2023 Dec 7, 2023
10-Q Quarterly report Oct 12, 2023 Aug 31, 2023
EFFECT Filing Sep 29, 2023 —
UPLOAD Letter from the SEC Sep 29, 2023 —
CORRESP Letter to the SEC Sep 29, 2023 —
S-3 Shelf registration Sep 28, 2023 —
DEF 14A Proxy statement Sep 27, 2023 Sep 27, 2023
8-K Current report
Regulation FD disclosure
 Sep 19, 2023 Sep 15, 2023
8-K Current report
Officer or director change
 Aug 28, 2023 Aug 28, 2023
10-K Annual report Aug 25, 2023 May 31, 2023
8-K Current report
Bylaw or fiscal year change
 Jul 26, 2023 Jul 24, 2023
8-K Current report
Regulation FD disclosure
 Apr 25, 2023 Apr 25, 2023
10-Q Quarterly report Apr 14, 2023 Feb 28, 2023
8-K Current report
Material agreement, Regulation FD disclosure
 Mar 7, 2023 Mar 3, 2023
424B5 Prospectus supplement Mar 7, 2023 —
424B5 Prospectus supplement Mar 2, 2023 —
424B5 Prospectus supplement Mar 2, 2023 —
8-K Current report
Officer or director change
 Mar 2, 2023 Mar 1, 2023
8-K Current report
Regulation FD disclosure
 Feb 7, 2023 Feb 7, 2023
10-Q Quarterly report Jan 13, 2023 Nov 30, 2022
8-K/A Amended current report
Shareholder vote results
 Dec 29, 2022 Dec 7, 2022
8-K Current report
Officer or director change
 Dec 16, 2022 Dec 16, 2022
8-K Current report
Officer or director change
 Dec 16, 2022 Dec 12, 2022
8-K Current report
Shareholder vote results
 Dec 9, 2022 Dec 7, 2022
8-K Current report
Officer or director change
 Dec 9, 2022 Dec 7, 2022
8-K Current report
Regulation FD disclosure
 Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Oct 13, 2022 Aug 31, 2022
DEF 14A Proxy statement Sep 27, 2022 Dec 7, 2022
10-K Annual report Aug 29, 2022 May 31, 2022
8-K Current report
Auditor change
 Apr 19, 2022 Apr 19, 2022
10-Q Quarterly report Apr 14, 2022 Feb 28, 2022
8-K Current report
Regulation FD disclosure, Other events
 Feb 10, 2022 Feb 8, 2022
10-Q Quarterly report Jan 12, 2022 Nov 30, 2021
8-K Current report
Results of operations, Other events
 Dec 16, 2021 Dec 16, 2021
8-K Current report
Shareholder vote results
 Dec 10, 2021 Dec 9, 2021
8-K Current report
Other events
 Dec 7, 2021 Dec 2, 2021
10-Q Quarterly report Oct 14, 2021 Aug 31, 2021
10-K/A Amended annual report Oct 14, 2021 May 31, 2021
8-K Current report
Restatement
 Sep 30, 2021 Sep 30, 2021
DEF 14A Proxy statement Sep 28, 2021 Dec 9, 2021
10-K Annual report Aug 27, 2021 May 31, 2021
8-K Current report
Regulation FD disclosure, Other events
 Jun 25, 2021 Jun 24, 2021
S-8 Employee stock plan registration May 21, 2021 —
10-Q Quarterly report Apr 14, 2021 Feb 28, 2021
8-K Current report
Other events
 Jan 22, 2021 Jan 22, 2021
424B5 Prospectus supplement Jan 22, 2021 —
10-Q Quarterly report Jan 14, 2021 Nov 30, 2020
8-K Current report
Regulation FD disclosure, Other events
 Jan 14, 2021 Jan 12, 2021
8-K Current report
Shareholder vote results
 Dec 11, 2020 Dec 11, 2020
8-K Current report
Officer or director change
 Dec 11, 2020 Dec 11, 2020
10-Q Quarterly report Oct 15, 2020 Aug 31, 2020
EFFECT Filing Sep 30, 2020 —
CORRESP Letter to the SEC Sep 28, 2020 —
DEF 14A Proxy statement Sep 25, 2020 Dec 10, 2020
CORRESP Letter to the SEC Sep 11, 2020 —
S-3/A Form s-3/a Sep 11, 2020 —
CORRESP Letter to the SEC Sep 9, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
 Sep 2, 2020 Aug 27, 2020
8-K Current report
Regulation FD disclosure
 Sep 2, 2020 Sep 1, 2020
10-K Annual report Aug 31, 2020 May 31, 2020
UPLOAD Letter from the SEC Jul 28, 2020 —
S-3 Shelf registration Jul 21, 2020 —
8-K Current report
Regulation FD disclosure, Other events
 Jun 29, 2020 Jun 29, 2020
8-K Current report
Regulation FD disclosure, Other events
 Jun 17, 2020 Jun 16, 2020
8-K Current report
Regulation FD disclosure, Other events
 Jun 2, 2020 Jun 1, 2020
8-K Current report
Regulation FD disclosure, Other events
 May 11, 2020 May 7, 2020
10-Q Quarterly report Apr 14, 2020 Feb 29, 2020
8-K Current report
Material agreement, Regulation FD disclosure
 Apr 6, 2020 Apr 1, 2020
8-K Current report
Other events
 Mar 20, 2020 Mar 20, 2020
424B5 Prospectus supplement Mar 20, 2020 —
8-K Current report
Other events
 Mar 18, 2020 Mar 17, 2020
D Filing Feb 27, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
 Feb 27, 2020 Feb 21, 2020
10-Q Quarterly report Jan 14, 2020 Nov 30, 2019
8-K Current report
Regulation FD disclosure
 Jan 9, 2020 Jan 9, 2020
8-K Current report
Shareholder vote results
 Dec 13, 2019 Dec 11, 2019
10-Q Quarterly report Oct 15, 2019 Aug 31, 2019
DEF 14A Proxy statement Sep 24, 2019 Dec 11, 2019
8-K Current report
Other events
 Sep 4, 2019 Sep 4, 2019
10-K Annual report Aug 29, 2019 May 31, 2019
8-K Current report
Other events
 Jun 5, 2019 May 31, 2019
10-Q Quarterly report Apr 15, 2019 Feb 28, 2019
8-K Current report
Other events
 Apr 9, 2019 Apr 5, 2019
8-K Current report
Officer or director change
 Mar 21, 2019 Mar 21, 2019
10-Q Quarterly report Jan 14, 2019 Nov 30, 2018
8-K Current report
Shareholder vote results
 Dec 14, 2018 Dec 13, 2018
10-Q Quarterly report Oct 15, 2018 Aug 31, 2018
DEF 14A Proxy statement Sep 28, 2018 Dec 12, 2018
8-K Current report
Regulation FD disclosure
 Sep 28, 2018 Sep 27, 2018
10-K Annual report Aug 29, 2018 May 31, 2018
8-K Current report
Other events
 Aug 27, 2018 Aug 22, 2018
S-8 Employee stock plan registration May 10, 2018 —
10-Q Quarterly report Apr 16, 2018 Feb 28, 2018
8-K Current report
Other events
 Mar 8, 2018 Dec 1, 2017
10-Q/A Amended quarterly report Jan 17, 2018 Nov 30, 2017
10-Q Quarterly report Jan 16, 2018 Nov 30, 2017
8-K Current report
Shareholder vote results
 Jan 10, 2018 Dec 13, 2017
8-K Current report
Material agreement
 Dec 4, 2017 Dec 1, 2017
424B5 Prospectus supplement Dec 4, 2017 —
10-Q Quarterly report Oct 16, 2017 Aug 31, 2017
DEF 14A Proxy statement Sep 28, 2017 Dec 13, 2017
10-K Annual report Aug 29, 2017 May 31, 2017
EFFECT Filing Jul 20, 2017 —
CORRESP Letter to the SEC Jul 18, 2017 —
UPLOAD Letter from the SEC Jul 6, 2017 —
S-3 Shelf registration Jun 30, 2017 —
10-Q Quarterly report Apr 14, 2017 Feb 28, 2017
10-Q Quarterly report Jan 17, 2017 Nov 30, 2016
10-Q Quarterly report Oct 17, 2016 Aug 31, 2016
DEF 14A Proxy statement Sep 28, 2016 Dec 14, 2016
8-K Current report
Other events
 Sep 12, 2016 Sep 12, 2016
10-K Annual report Aug 29, 2016 May 31, 2016
CERTNAS Auto-generated paper document Aug 26, 2016 —
8-A12B Form 8-a12b Aug 23, 2016 —
8-K Current report
Other events
 Aug 10, 2016 Aug 10, 2016
8-K Current report
Officer or director change
 Jul 18, 2016 Jul 14, 2016
8-K Current report
Material agreement, Unregistered share sale
 May 26, 2016 May 25, 2016
10-Q Quarterly report Apr 14, 2016 Feb 29, 2016
8-K Current report
Other events
 Mar 16, 2016 Mar 15, 2016
10-Q Quarterly report Jan 14, 2016 Nov 30, 2015
10-Q Quarterly report Oct 15, 2015 Aug 31, 2015
DEF 14A Proxy statement Sep 28, 2015 Dec 16, 2015
10-K Annual report Aug 31, 2015 May 31, 2015
S-8 Employee stock plan registration May 22, 2015 —
10-Q Quarterly report Apr 14, 2015 Feb 28, 2015
10-Q Quarterly report Jan 14, 2015 Nov 30, 2014
10-Q Quarterly report Oct 15, 2014 Aug 31, 2014
DEF 14A Proxy statement Sep 29, 2014 Dec 15, 2014
10-K Annual report Aug 29, 2014 May 31, 2014
10-Q Quarterly report Apr 14, 2014 Feb 28, 2014
10-Q Quarterly report Jan 14, 2014 Nov 30, 2013
10-Q Quarterly report Oct 15, 2013 Aug 31, 2013
DEF 14A Proxy statement Sep 30, 2013 Dec 11, 2013
10-K Annual report Aug 29, 2013 May 31, 2013
10-Q Quarterly report Apr 15, 2013 Feb 28, 2013
8-K Current report
Unregistered share sale
 Apr 15, 2013 Apr 8, 2013
8-K Current report
Material agreement, Agreement ended
 Apr 8, 2013 Apr 2, 2013
10-Q Quarterly report Jan 14, 2013 Nov 30, 2012
10-Q Quarterly report Oct 12, 2012 Aug 31, 2012
DEF 14A Proxy statement Sep 28, 2012 Dec 11, 2012
10-K Annual report Aug 29, 2012 May 31, 2012
10-Q Quarterly report Apr 16, 2012 Feb 29, 2012
S-8 Employee stock plan registration Feb 9, 2012 —
10-Q Quarterly report Jan 17, 2012 Nov 30, 2011
10-Q/A Amended quarterly report Oct 27, 2011 Aug 31, 2011
10-Q Quarterly report Oct 17, 2011 Aug 31, 2011
DEF 14A Proxy statement Sep 28, 2011 Sep 28, 2011
NT 10-K Form nt 10-k Aug 30, 2011 May 31, 2011
10-K Annual report Aug 30, 2011 Jul 29, 2011
10-Q Quarterly report Apr 14, 2011 Feb 28, 2011
10-Q Quarterly report Jan 14, 2011 Nov 30, 2010
10-Q Quarterly report Oct 15, 2010 Aug 31, 2010
DEF 14A Proxy statement Sep 29, 2010 Dec 15, 2010
10-K Annual report Aug 30, 2010 May 31, 2010
10-Q Quarterly report Apr 14, 2010 Feb 28, 2010
10-Q Quarterly report Jan 19, 2010 Nov 30, 2009
NT 10-Q Notice of late filing Jan 15, 2010 Nov 30, 2009
10-Q Quarterly report Oct 16, 2009 Aug 31, 2009
NT 10-Q Biomerica, inc. Oct 16, 2009 Aug 31, 2009
DEF 14A Proxy statement Sep 29, 2009 Dec 10, 2009
10-K Annual report Aug 31, 2009 May 31, 2009

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
BMRA (Nasdaq)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Irvine, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
73290

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.